Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS)

CNY 23.8

(0.68%)

Net Debt Summary of Nanjing Well Pharmaceutical Group Co.,Ltd.

  • Nanjing Well Pharmaceutical Group Co.,Ltd.'s latest annual net debt in 2023 was 329.41 Million CNY , up 0.97% from previous year.
  • Nanjing Well Pharmaceutical Group Co.,Ltd.'s latest quarterly net debt in 2024 Q3 was 205.81 Million CNY , down -38.46% from previous quarter.
  • Nanjing Well Pharmaceutical Group Co.,Ltd. reported annual net debt of 326.23 Million CNY in 2022, up 144.13% from previous year.
  • Nanjing Well Pharmaceutical Group Co.,Ltd. reported annual net debt of 133.62 Million CNY in 2021, up 228.23% from previous year.
  • Nanjing Well Pharmaceutical Group Co.,Ltd. reported quarterly net debt of 315.57 Million CNY for 2024 Q1, down -4.2% from previous quarter.
  • Nanjing Well Pharmaceutical Group Co.,Ltd. reported quarterly net debt of 358.97 Million CNY for 2024 Q2, up 13.75% from previous quarter.

Annual Net Debt Chart of Nanjing Well Pharmaceutical Group Co.,Ltd. (2023 - 2014)

Historical Annual Net Debt of Nanjing Well Pharmaceutical Group Co.,Ltd. (2023 - 2014)

Year Net Debt Net Debt Growth
2023 329.41 Million CNY 0.97%
2022 326.23 Million CNY 144.13%
2021 133.62 Million CNY 228.23%
2020 40.71 Million CNY 151.72%
2019 -78.71 Million CNY -244.9%
2018 54.32 Million CNY 486.33%
2017 9.26 Million CNY 184.12%
2016 -11.01 Million CNY -112.05%
2015 91.42 Million CNY 11.3%
2014 82.13 Million CNY 0.0%

Peer Net Debt Comparison of Nanjing Well Pharmaceutical Group Co.,Ltd.

Name Net Debt Net Debt Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. -6.15 Billion CNY 105.352%
Yabao Pharmaceutical Group Co., Ltd -408.64 Million CNY 180.611%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited -5.48 Billion CNY 106.01%
Harbin Pharmaceutical Group Co., Ltd. 498.52 Million CNY 33.923%
Tasly Pharmaceutical Group Co., Ltd -1.49 Billion CNY 122.09%
Zhejiang Medicine Co., Ltd. -658.58 Million CNY 150.018%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited -1.28 Billion CNY 125.628%
Lionco Pharmaceutical Group Co.,Ltd. 222.19 Million CNY -48.254%
Humanwell Healthcare (Group) Co.,Ltd. 5.84 Billion CNY 94.362%
Ginwa Enterprise (Group) Inc. -609.67 Million CNY 154.031%
Joincare Pharmaceutical Group Industry Co.,Ltd. -8.29 Billion CNY 103.973%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. -179.97 Million CNY 283.028%
China Animal Husbandry Industry Co., Ltd. -36.84 Million CNY 994.052%
Jiangsu Jibeier Pharmaceutical Co., Ltd. -684.96 Million CNY 148.092%
Zhejiang Huahai Pharmaceutical Co., Ltd. 6.1 Billion CNY 94.609%
Shanghai Haoyuan Chemexpress Co., Ltd. 598.96 Million CNY 45.003%
Ningbo Menovo Pharmaceutical Co., Ltd. 846.41 Million CNY 61.082%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd -2.47 Billion CNY 113.291%
Chongqing Taiji Industry(Group) Co.,Ltd 2.92 Billion CNY 88.742%
HPGC Renmintongtai Pharmaceutical Corporation 1.01 Billion CNY 67.666%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 276.38 Million CNY -19.185%
Henan Lingrui Pharmaceutical Co., Ltd. -1.34 Billion CNY 124.408%
Shenzhen Chipscreen Biosciences Co., Ltd. 828.33 Million CNY 60.232%
Guizhou Yibai Pharmaceutical Co., Ltd. 379.62 Million CNY 13.227%
Jiangsu Kanion Pharmaceutical Co.,Ltd. -1.92 Billion CNY 117.147%
Zhongzhu Healthcare Holding Co.,Ltd -330.03 Million CNY 199.811%
Beijing Tongrentang Co., Ltd -8.7 Billion CNY 103.784%
KPC Pharmaceuticals, Inc. -321.76 Million CNY 202.378%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. -1.17 Billion CNY 127.949%
North China Pharmaceutical Company Ltd. 10.74 Billion CNY 96.933%
China Resources Double-Crane Pharmaceutical Co.,Ltd. -2.75 Billion CNY 111.964%
Tibet Weixinkang Medicine Co., Ltd. -261.74 Million CNY 225.853%
China National Medicines Corporation Ltd. -7.76 Billion CNY 104.241%
Zhejiang Hisun Pharmaceutical Co., Ltd. 4.1 Billion CNY 91.976%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 1.69 Billion CNY 80.586%
ChengDu ShengNuo Biotec Co.,Ltd. 48.09 Million CNY -584.947%
Dali Pharmaceuticalco.,Ltd 9.46 Million CNY -3379.009%
Changchun BCHT Biotechnology Co. -421.7 Million CNY 178.114%
Zhejiang Shengda Bio-Pharm Co., Ltd. -85.28 Million CNY 486.266%
Shanghai Jiaoda Onlly Co.,Ltd 44.83 Million CNY -634.774%
Jiang Zhong Pharmaceutical Co.,Ltd -1.27 Billion CNY 125.81%
Mayinglong Pharmaceutical Group Co., LTD. -2.6 Billion CNY 112.632%
Cisen Pharmaceutical Co., Ltd. -812.71 Million CNY 140.532%
Hunan Warrant Pharmaceutical Co.,Ltd -355.46 Million CNY 192.671%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 25.97 Billion CNY 98.732%
Jianmin Pharmaceutical Group Co.,Ltd. 196.05 Million CNY -68.021%
Hunan Fangsheng Pharmaceutical Co., Ltd. 470.72 Million CNY 30.02%
Guangxi Wuzhou Zhongheng Group Co.,Ltd -1.17 Billion CNY 127.947%
Guobang Pharma Ltd. -1.13 Billion CNY 129.129%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 495.29 Million CNY 33.492%
Kangmei Pharmaceutical Co., Ltd. -801.59 Million CNY 141.095%
Shandong Buchang Pharmaceuticals Co., Ltd. 2.71 Billion CNY 87.867%
Zhejiang Starry Pharmaceutical Co.,Ltd. 2.62 Billion CNY 87.457%
Henan Taloph Pharmaceutical Stock Co.,Ltd 622.63 Million CNY 47.094%
ZhuZhou QianJin Pharmaceutical Co.,Ltd -1.88 Billion CNY 117.511%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 1.41 Billion CNY 76.735%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. -244.27 Million CNY 234.851%
Shanghai Shyndec Pharmaceutical Co., Ltd. -3.47 Billion CNY 109.48%
Shanghai Yizhong Pharmaceutical Co., Ltd. -870.73 Million CNY 137.831%
Tibet Rhodiola Pharmaceutical Holding Co. -184.66 Million CNY 278.383%
Sichuan Huiyu Pharmaceutical Co., Ltd. -1.34 Billion CNY 124.456%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 149.69 Million CNY -120.049%
CanSino Biologics Inc. 656.66 Million CNY 49.835%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 424.4 Million CNY 22.382%
Shandong Lukang Pharmaceutical Co.,Ltd. 2.63 Billion CNY 87.507%